Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-029699
Filing Date
2019-12-19
Accepted
2019-12-19 20:54:26
Documents
1
Period of Report
2019-12-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 14315
  Complete submission text file 0000899243-19-029699.txt   15638
Mailing Address C/O DICERNA PHARMACEUTICALS, INC. 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address
FAMBROUGH DOUGLAS (Reporting) CIK: 0001259856 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36281 | Film No.: 191297508

Mailing Address 33 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 33 HAYDEN AVENUE LEXINGTON MA 02421 617 621 8097
Dicerna Pharmaceuticals Inc (Issuer) CIK: 0001399529 (see all company filings)

EIN.: 205993609 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations